A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: Outcome at four years

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 9, 1999, Pages 1002-

  Sinha, Anita ^a  

^a DERBY CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST CONTROL; DEVELOPING COUNTRY; ENDOMETRIUM ABLATION; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; LETTER; METRORRHAGIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERUS BLEEDING;

CATHETER ABLATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; RANDOMIZED CONTROLLED TRIALS; UTERINE HEMORRHAGE;

EID: 0032834385     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08452.x     Document Type: Article

References (3)

1. Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. Br J Obstet Gynaecol 1999; 106: 360-366.
2. Sculpher MJ, Dwyer N, Byford S, Stirrat GM. Randomised trial comparing hysterectomy and transcervical resection: effect on health related quality of life and costs two years after surgery. Br J Obstet Gynaecol 1996; 103: 142-149.
3. Valle RF, Baggish MS. Endometrial cancer after endometrial ablation: high risk factors predicting its occurrence. Am J Obstet Gynecol 1998; 179 569-573.